228 related articles for article (PubMed ID: 25182148)
21. ASSOCIATION ANALYSIS OF PIOGLITAZONE EFFECTIVENESS IN TREATMENT OF NAFLD PATIENTS WITH OBESITY AND PPARG RS1801282 (PRO12ALA) GENOTYPE.
Shypulin VP; Martynchuk OA; Rudenko NN; Koliada AK; Tishchenko VV; Melnyk NH
Wiad Lek; 2021; 74(7):1617-1621. PubMed ID: 34459761
[TBL] [Abstract][Full Text] [Related]
22. Association of the rs6235 variant in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene with obesity and related traits in a Taiwanese population.
Hsiao TJ; Hwang Y; Chang HM; Lin E
Gene; 2014 Jan; 533(1):32-7. PubMed ID: 24140494
[TBL] [Abstract][Full Text] [Related]
23. Association between PPARγ2 Pro12Ala polymorphism and myocardial infarction and obesity in Han Chinese in Hohhot, China.
Wang LP; Zhao LR; Cui HW; Yan MR; Yang L; Su XL
Genet Mol Res; 2012 Aug; 11(3):2929-38. PubMed ID: 22653647
[TBL] [Abstract][Full Text] [Related]
24. Association study of rs1801282 PPARG gene polymorphism and immune cells and cytokine levels in a Spanish pregnant women cohort and their offspring.
García-Ricobaraza M; García-Bermúdez M; Torres-Espinola FJ; Segura Moreno MT; Bleyere MN; Díaz-Prieto LE; Nova E; Marcos A; Campoy C
J Biomed Sci; 2020 Nov; 27(1):101. PubMed ID: 33250050
[TBL] [Abstract][Full Text] [Related]
25. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
26. G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.
Li S; He C; Nie H; Pang Q; Wang R; Zeng Z; Song Y
Front Endocrinol (Lausanne); 2022; 13():919087. PubMed ID: 35846293
[TBL] [Abstract][Full Text] [Related]
27. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
[TBL] [Abstract][Full Text] [Related]
28. The ENPP1 K121Q polymorphism is associated with type 2 diabetes and related metabolic phenotypes in a Taiwanese population.
Hsiao TJ; Lin E
Mol Cell Endocrinol; 2016 Sep; 433():20-5. PubMed ID: 27238374
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes.
Namvaran F; Azarpira N; Rahimi-Moghaddam P; Dabbaghmanesh MH
Eur J Pharmacol; 2011 Dec; 671(1-3):1-6. PubMed ID: 21968139
[TBL] [Abstract][Full Text] [Related]
30. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
32. PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.
García-Broncano P; Berenguer J; Fernández-Rodríguez A; Pineda-Tenor D; Jiménez-Sousa MÁ; García-Alvarez M; Miralles P; Aldámiz-Echevarria T; López JC; Micheloud D; Resino S
J Transl Med; 2014 Aug; 12():235. PubMed ID: 25159899
[TBL] [Abstract][Full Text] [Related]
33. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
Ghoussaini M; Meyre D; Lobbens S; Charpentier G; Clément K; Charles MA; Tauber M; Weill J; Froguel P
BMC Med Genet; 2005 Mar; 6():11. PubMed ID: 15784141
[TBL] [Abstract][Full Text] [Related]
34. Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
Bozina T; Simić I; Lovrić J; Pećin I; Jelaković B; Sertić J; Reiner Z
Coll Antropol; 2013 Sep; 37(3):801-8. PubMed ID: 24308220
[TBL] [Abstract][Full Text] [Related]
35. Targeted sequencing analysis of PPARG identifies a risk variant associated with obstructive sleep apnea in Chinese Han subjects.
Jiao X; Yang S; Yang Y; Li J; Sun H; Zhang M; Yang Y; Qin Y
Sleep Breath; 2020 Mar; 24(1):167-174. PubMed ID: 31044373
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Peroxisome Proliferator-Activated Receptor Gamma and Its Interaction with Abdominal Obesity on Diabetic Nephropathy in Chinese Han.
Zhang M; Yuan H; Li C; Li C
Nephron; 2017; 135(3):224-230. PubMed ID: 28013303
[TBL] [Abstract][Full Text] [Related]
37. An age-dependent diet-modified effect of the PPARγ Pro12Ala polymorphism in children.
Dedoussis GV; Manios Y; Kourlaba G; Kanoni S; Lagou V; Butler J; Papoutsakis C; Scott RA; Yannakoulia M; Pitsiladis YP; Hirschhorn JN; Lyon HN
Metabolism; 2011 Apr; 60(4):467-73. PubMed ID: 20580778
[TBL] [Abstract][Full Text] [Related]
38. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
[TBL] [Abstract][Full Text] [Related]
39. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator activated receptor gamma 34C>G variant and anthropometric parameters in metabolic syndrome.
Zafar U; Khaliq S; Ahmad HU; Lone KP
J Pak Med Assoc; 2019 Sep; 69(9):1259-1265. PubMed ID: 31511709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
